Jeffrey S. Hatfield
CIK 1609879 · Chief Executive Officer · last filed 2026-05-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$342.7K
Companies
8
Total Filings
33
Lifetime Open-Market Net
-$1.42M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| VIR | Director | 39,806 | $8.61 | $342.7K | $0 | 7 | 2026-05-28 |
| VRDN | Director | — | $16.35 | — | $0 | 1 | 2021-02-08 |
| Viridian Therapeutics, Inc.\DE (MGEN) Delisted | Director | — | — | — | $0 | 3 | 2020-05-22 |
| LIFE | Director | — | $15.61 | — | $0 | 5 | 2020-05-08 |
| Larimar Therapeutics, Inc. (ZFGN) Delisted | Chief Executive Officer | — | — | — | $0 | 4 | 2019-01-24 |
| INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Director | — | $0.32 | — | $0 | 2 | 2018-01-23 |
| Vitae Pharmaceuticals, Inc (VTAE) Delisted | Chief Executive Officer | 244,996 | — | — | -$1.42M | 10 | 2016-10-25 |
| AMBIT BIOSCIENCES CORP (AMBI) Delisted | Director | — | $0.54 | — | $0 | 1 | 2014-11-12 |
Recent Filings · Page 3 of 4
33 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-04 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2016-11-03 | INVIVO THERAPEUTICS HOLDINGS CORP. (NVIV) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-10-25 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Mixed | −244,996 | -$5.14M | EDGAR |
| 2016-09-16 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Sell (S) | −50,000 | -$1.04M | EDGAR |
| 2016-08-17 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Grant (A) | +747 | $4.6K | EDGAR |
| 2016-02-16 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-01-25 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Exer (M) | +26,537 | $91.6K | EDGAR |
| 2015-12-28 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Mixed | +26,537 | -$213.6K | EDGAR |
| 2015-03-17 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Tax (F) | −171,156 | -$1.91M | EDGAR |
| 2015-03-09 | Vitae Pharmaceuticals, Inc (VTAE) Delisted | Exer (M) | +8,115 | $9.3K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.